19/11/2020 – Polifarma SpA, an Italian pharmaceutical company born 100 years ago, is delighted to announce the exclusive dealership agreement of a Medical Device Line named Sanispira made with HSD Europe, a medical device manufacturing company. According to this agreement, Pollifarma will be in charge of all the scientific information activities and the distribution of the product both in Italy and abroad.

To be more specific, Sanispira is a line of technologically advanced nasal filter suitable for different therapeutic areas (E.N.T., primary care, allergology) with several ways of use.

The support of the latest clinical trials confirms the importance of these products in the target market.

Sanispira includes the following medical devices: SANISPIRA Virus and bacteria, SANISPIRA Allergy, SANISPIRA SweetDreams.

“This agreement, signed in a very peculiar and difficult period, confirms the company’s willing of supporting a never-ending development process that includes the broadening of its portfolio with new products intended for the HCP,” claims Andrea Bracci, CEO of Polifarma SpA, “Once more, Polifarma shows its reliability to both doctors and patients all around the world, ensuring the high efficiency and quality that have distinguished it since 1919”.